Antithrombotic Therapy at the End of Life: The PEACE Study

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

NCT Number	NCT07338071
Lead Sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS Collaborators: Ospedale Cristo Re - Roma, San Giovanni Addolorata Hospital
Conditions	Palliative Care
Enrollment	410 participants
Start Date	2026-01
Primary Completion	2027-11 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-01-13